Skip to main content

Table 9 Logistic regression analysis of factors associated with transaminase elevation among Rosuvastatin users (N = 323)

From: Pharmacogenomic insights into atorvastatin and rosuvastatin adverse effects: a prospective observational study in the UAE’s multiethnic population

Independent Variables

P-Value

Adjusted Odd Ratio (OR)

95% CI (Lower)

95% CI (Upper)

Combination therapy (Ezetimibe)

0.040

2.053

1.032

4.087

ABCG2 rs2231142

Carriers

0.002

3.222

1.554

6.680

Ethnicity (Arab)

0.373

0.697

0.315

1.541

Alcohol use

0.260

1.589

0.710

3.560